⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 28, 2024

TABLE 3 from First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study

Duncan Wheatley Rossana Berardi Miguel Á. Climent Durán Anna Tomiak Alastair Greystoke Anthony M. Joshua Hendrik‐Tobias Arkenau Lajos Géczi Javier Garciá Corbacho Luis Paz‐Ares Syed A. Hussain Luboš Petruželka Angelo Delmonte Colombe Chappey Joanna C. Masters Elisabete Michelon Danielle Murphy Sandrine Mwewa Rossano Cesari Bernard Doger de Spéville

View at Publisher

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Summary of efficacy in the urothelial carcinoma and NSCLC cohorts

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wheatley et al. (2024) studied this question.

synapsesocial.com/papers/68e62d5fb6db6435875bf6e0 https://doi.org/10.1158/2767-9764.26125383.v1

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1TABLE 3 from First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study2024
2TABLE 1 from First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study2024
3TABLE 1 from First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study2024
4TABLE 2 from First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study2024
5TABLE 2 from First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study2024

More related papers

FIGURE 1 from First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study2024
Data from First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study2024
First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study2024